| | | |   | | | | By Ed Silverman This “appears to fit into the EEOC’s priority for filing lawsuits based on systemic discrimination" said Cornell University's Risa Lieberwitz Read More | | By Matthew Herper Molly Ferguson for STAT The Alzheimer's drug lecanemab clearly succeed in its randomized controlled trials, a reminder of all the ways in which Aduhelm didn't. Read More | | By Andrew Joseph Adobe Lecanumab succeeded in a trial, but doctors' early verdict range from "more days of independence" to "I wish I could be more impressed." Read More | | Sponsor content by Nuance Meet the healthcare initiative designed to improve quality The Quality Care Collaborative (QCC), which combines Nuance's nationwide Precision Imaging Network and Covera's Diagnostic Intelligence Platform, provides a workflow-integrated infrastructure that enables more radiology providers to access quality analytics and support improved diagnostic precision through trusted, widely deployed technology. It fosters a continuous quality improvement partnership between providers, payors, and employers as they work together in a trusted and secure setting on long-term, sustainable quality improvement programs, peer-learning initiatives, and value-based care efforts. Learn more. | | By Usha Lee McFarling Verónica Cárdenas for STAT Residents' wariness of outsiders demonstrates the need for Alzheimer's researcher Gladys Maestre's unorthodox, community-centered approach. Read More | | By Casey Ross Jacquelyn Martin/AP New guidance from the FDA on artificial intelligence tools is triggering strong reaction from researchers and regulatory experts. Read More | |
No comments